FDA Denies Amphastar's New Primatene Mist Inhaler

Amphastar Pharmaceuticals Inc. said Tuesday that the U.S. Food and Drug Administration had denied its new drug application for its over-the-counter Primatene Mist asthma inhaler.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news